CytoMed Therapeutics Limited
GDTCHealthcare|Biotechnology|SG
$0.86
-0.02 (-2.39%)
DCF Value
$1.16
Tangible Book / Share
$0.45
Cash / Share
$0.12
Analyst Consensus
Buy1 analysts
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Rating Trend
Jun 24
1 buy · 0 hold · 0 sell
Jul 24
1 buy · 0 hold · 0 sell
Aug 24
1 buy · 0 hold · 0 sell
Sep 24
1 buy · 0 hold · 0 sell
Oct 24
1 buy · 0 hold · 0 sell
Nov 24
1 buy · 0 hold · 0 sell
Dec 24
1 buy · 0 hold · 0 sell
Jan 25
1 buy · 0 hold · 0 sell
Sep 26
1 buy · 0 hold · 0 sell
Oct 26
1 buy · 0 hold · 0 sell
Nov 26
1 buy · 0 hold · 0 sell
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| Benchmark | maintain | Speculative Buy | Oct 10, 2024 |
| Benchmark | maintain | Speculative Buy | Jun 11, 2024 |
| Benchmark | maintain | Speculative Buy | Dec 4, 2023 |
Earnings History
Next report: Nov 13, 2026| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Sep 30, 2026 | $-0.12 | — | $121.7K | — |
| Mar 31, 2026 | $-0.11 | — | $130.5K | — |
| Sep 30, 2025 | $-0.07 | — | $105.7K | — |
| Apr 28, 2025 | $-0.07 | $-0.04 | $100.0K | $130.0K |
| Sep 30, 2024 | $-0.07 | $-0.03 | $82.7K | $156.0K |
| Apr 22, 2024 | $-0.03 | $-0.02 | $83.1K | $115.3K |
| Feb 28, 2024 | $-0.06 | — | $84.6K | — |
| Nov 17, 2023 | $-0.22 | — | $81.8K | — |